Emerging Role of Bevacizumab in Management of Patients With Symptomatic Hepatic Involvement in Hereditary Hemorrhagic Telangiectasia

American Journal of Hematology- United States

doi 10.1002/ajh.24878

Full Text

Abstract

Available in

Categories

Date

August 24, 2017

Authors

Silke Schumann-Binarsch

Bernhard Schmuck

Franziska Oltmer

Urban Geisthoff

Kornelia Wirsching

Juergen Klempnauer

Rohit Philip Thomas

Claus-Henning Köhne

Publisher

Wiley

Related search

Hereditary Hemorrhagic Telangiectasia

English

Hereditary Hemorrhagic Telangiectasia

English

Hereditary Hemorrhagic Telangiectasia

Pediatric Neurology Briefs

English

Life Expectancy and Comorbidities in Patients With Hereditary Hemorrhagic Telangiectasia

Vascular Medicine

Cardiovascular Medicine

English

A Case of Hereditary Hemorrhagic Telangiectasia With Hepatic Encephalopathy Due to Portal Hepatic Venous Shunt

Japanese Journal of Geriatrics

English

Interdisciplinary Management of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) at a German Center of Excellence

English

Variant Analysis in Chinese Families With Hereditary Hemorrhagic Telangiectasia

Molecular genetics & genomic medicine

Molecular Biology

English

Topical Propranolol Improves Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia - A Preliminary Report

Journal of Otolaryngology - Head and Neck Surgery

Otorhinolaryngology

English

Gastrointestinal Bleeding in Patients With Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings

Journal of Clinical Medicine

English